# OnCo record paper-shaw-crizotinib-ros1-nejm-2014 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-shaw-crizotinib-ros1-nejm-2014/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-shaw-crizotinib-ros1-nejm-2014" ;
  schema:name "Crizotinib in ROS1-rearranged non-small-cell lung cancer"@en ;
  schema:description "Crizotinib shrank tumours in almost three quarters of patients with ROS1-rearranged lung cancer and controlled the disease for a median of 19 months, establishing ROS1 as a targetable driver and leading to the first approval."@en ;
  schema:url <https://onco.cc/key-papers/paper-shaw-crizotinib-ros1-nejm-2014/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1406766>, <https://pubmed.ncbi.nlm.nih.gov/25264305/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1406766> ;
  schema:datePublished "2014"^^xsd:gYear ;
  schema:author "Shaw AT, Ou SH, Bang YJ, et al." ;
  onco:cancers <https://onco.cc/cancers/ros1-positive-nsclc/> ;
  onco:drugs <https://onco.cc/drugs/crizotinib/> ;
  onco:journals <https://onco.cc/journals/nejm/> .